Detroit Genetic Evaluation of Multiple Cancers (GEMS)

Detroit Genetic Evaluation of Multiple CancerS (GEMS)

Detroit GEMS is a research study of cancer patients and survivors. This study is being done to learn more about what potentially makes someone more likely to develop multiple cancers. Previous research demonstrates that inherited (or genetic) factors can contribute to multiple cancer diagnoses. But it also tells us there are non-inherited (or environmental) factors that can play a role in the development of multiple cancers, too. Detroit GEMS aims to evaluate all of these potential factors to advance the knowledge and screening recommendations for cancer patients, their families and those who are at-risk of a cancer diagnosis.

Before Detroit GEMS, our team conducted extensive survivorship research in the Detroit Research on Cancer Survivors (ROCS) study and in the Cancer Survivorship in Metropolitan Detroit (CSMD) study. Collectively, those projects recruited over 5000 cancer survivors to learn more about the quality of life and other outcomes in cancer survivors living in Metro-Detroit. The work from Detroit ROCS and CSMD led to dozens of publications and insights for the cancer community. Additionally, multiple studies are now underway, building upon the initial data collected in Detroit ROCS and CSMD. To learn more about the Detroit ROCS study visit https://detroitrocs.org

 

 

 

Detroit GEMS is the newest project funded by the National Institutes of Health, with the intent of building upon the ROCS infrastructure.

If you received an introductory packet asking if you would like to participate in the Detroit GEMS study and you would like to complete you survey, please click the link below and use the login information provided in your packet. If you have any questions or would like assistance completing your survey, please contact us by email at DetroitGEMS@wayne.edu or call 1-855-794-4577.


In The News

A team of researchers from Wayne State University (WSU) received a five-year grant from the National Cancer Institute of the National Institutes of Health for the study “Genetic Variation in Cancer Risk and Outcomes in African Americans.” This is a Program Project Grant that includes three large studies. The team will work to improve the identification and clinical management of hereditary and multiple primary cancers.

The launch of this important study was announced in 2024 by the WSU School of Medicine.